Valuation GlaxoSmithKline Pharmaceuticals Limited NSE India S.E.

Stocks

Market Closed - NSE India S.E. Other stock markets 14:05:08 31/07/2026 +03			5-day change	1st Jan Change
2,655.40 ^INR	+1.71%		+5.61%	+7.35%

05-29	GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Dr. Simrat Sohal from Compliance Officer and Ceases to Be the Senior Management Personnel, Effective August 5, 2026	CI
05-13	GlaxoSmithKline Pharmaceuticals Clocks Higher Fiscal Q4 Consolidated Net Profit	MT

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	281,714	224,319	329,173	487,432	386,822	449,510	-
Change	-	-20.37%	46.74%	48.08%	-20.64%	16.21%	-
Enterprise Value (EV)	256,351	207,663	329,173	487,432	386,822	449,510	449,510
Change	-	-18.99%	58.51%	48.08%	-20.64%	16.21%	0%
P/E	16.6x	36.7x	55.8x	52.5x	37.3x	39.1x	34.7x
PBR	10.6x	12.9x	18.5x	25x	17.1x	17.1x	13.5x
PEG	-	-0.6x	-16.49x	0.9x	3.2x	3.5x	2.7x
Capitalization / Revenue	8.59x	6.9x	9.53x	13x	10.1x	10.7x	9.67x
EV / Revenue	0x	0x	0x	0x	0x	10.7x	9.67x
EV / EBITDA	0x	0x	0x	0x	0x	30.8x	27.3x
EV / EBIT	0x	0x	0x	0x	0x	32.7x	28.6x
EV / FCF	0x	0x	0x	0x	0x	38.8x	35x
FCF Yield	2.75%	1.96%	1.67%	2.6%	2.19%	2.58%	2.86%
Dividend per Share ²	30	32	32	42	57	29.5	29.5
Rate of return	1.8%	2.42%	1.65%	1.46%	2.5%	1.11%	1.11%
EPS ²	100	36.05	34.83	54.76	61.15	67.9	76.48
Distribution rate	30%	88.8%	91.9%	76.7%	93.2%	43.4%	38.6%
Net sales ¹	32,780	32,517	34,537	37,492	38,217	41,989	46,489
EBITDA ¹	8,273	8,043	9,087	11,774	13,092	14,603	16,493
EBIT ¹	7,592	7,385	8,390	11,106	12,428	13,760	15,728
Net income ¹	16,947	6,107	5,900	9,276	10,360	11,417	12,543
Net Debt	-25,363	-16,656	-	-	-	-	-
Reference price ²	1,662.95	1,324.15	1,943.10	2,877.30	2,283.40	2,653.45	2,653.45
Nbr of stocks (in thousands)	169,406	169,406	169,406	169,406	169,406	169,406	-
Announcement Date	5/16/22 A	5/17/23 A	5/17/24 A	5/13/25 A	5/13/26 A	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.03x	12.19x	25.61x	0.59%	1,024B
JOHNSON & JOHNSON	27.48x	6.29x	17.54x	2.1%	618B
ABBVIE INC.	32.57x	7.42x	15.35x	2.76%	443B
ROCHE HOLDING AG	19.7x	4.68x	11.59x	2.83%	349B
ASTRAZENECA PLC	21.76x	4.48x	12.7x	1.96%	264B
NOVO NORDISK A/S	13.48x	5.05x	10.4x	3.71%	209B
AMGEN INC.	25.29x	6.61x	11.66x	2.62%	208B
GILEAD SCIENCES, INC.	-46.92x	5.63x	31.08x	2.53%	162B
PFIZER INC.	12.69x	3.11x	7.86x	6.88%	143B
Average	15.68x	6.16x	15.98x	2.89%	379.88B
Weighted average by Cap.	24.04x	7.68x	18.14x	2.14%